European Society of Cardiology Quality Indicators for the care and outcomes of cardiac pacing: developed by the Working Group for Cardiac Pacing Quality Indicators in collaboration with the European Heart Rhythm Association of the European Society of Cardiology
Year: 2021
Type: review
Abstract: AIMS: To develop a suite of quality indicators (QIs) for the evaluation of the care and outcomes for adults undergoing cardiac pacing. METHODS AND RESULTS: Under the auspice of the Clinical Practice Guideline Quality Indicator Committee of the European Society of Cardiology (ESC), the Working Group for cardiac pacing QIs was formed. The Group comprised Task Force members of the 2021 ESC Clinical Practice Guidelines on Cardiac Pacing and Cardiac Resynchronization Therapy, members of the European Heart Rhythm Association, international cardiac device experts, and patient representatives. We followed the ESC methodology for QI development, which involved (i) the identification of the key domains of care by constructing a conceptual framework of the management of patients receiving cardiac pacing, (ii) the development of candidate QIs by conducting a systematic review of the literature, (iii) the selection of the final set of QIs using a modified-Delphi method, and (iv) the evaluation of the feasibility of the developed QIs. Four domains of care were identified: (i) structural framework, (ii) patient assessment, (iii) pacing strategy, and (iv) clinical outcomes. In total, seven main and four secondary QIs were selected across these domains and were embedded within the 2021 ESC Guidelines on Cardiac Pacing and Cardiac Resynchronization therapy. CONCLUSION: By way of a standardized process, 11 QIs for cardiac pacing were developed. These indicators may be used to quantify adherence to guideline-recommended clinical practice and have the potential to improve the care and outcomes of patients receiving cardiac pacemakers.
Source: EP Europace
Authors: Suleman Aktaa, Amr Abdin, Elena Arbelo, Haran Burri, Kevin Vernooy, Carina Blomström-Lundqvist, Giuseppe Boriani, Pascal Defaye, Jean-Claude Deharo, Inga Drossart, Dan Foldager, Michael R Gold, Jens Brock Johansen, Francisco Leyva, Cecilia Linde, Yoav Michowitz, Mads Brix Kronborg, David Slotwiner, Torkel Steen, José Maria Tolosana, Stylianos Tzeis, Niraj Varma, Michael Glikson, Jens Cosedis Nielsen, Chris P Gale
Institutions: University of Leeds, Leeds Teaching Hospitals NHS Trust, Universitätsklinikum des Saarlandes, Centro de Investigación en Red en Enfermedades Cardiovasculares, Centro de Investigación Biomédica en Red, Hospital Clínic de Barcelona, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Universitat de Barcelona, University Hospital of Geneva, Maastricht University Medical Centre, Maastricht University, Uppsala University, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria di Modena, Centre Hospitalier Universitaire de Grenoble, Université Grenoble Alpes, Inserm, Aix-Marseille Université, Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement, Hôpital de la Timone, European Society of Cardiology, Medical University of South Carolina, Odense University Hospital, Aston University, Queen Elizabeth Hospital Birmingham, Karolinska University Hospital, Karolinska Institutet, Hebrew University of Jerusalem, Shaare Zedek Medical Center, Bikur Cholim Hospital, Aarhus University, Aarhus University Hospital, Weill Cornell Medicine, Oslo University Hospital, Hygeia Hospital, Mitera Hospital, Cleveland Clinic
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,592
Funder: Novo Nordisk Fonden
Award: G6162339058
OpenAlex ID: W3196720277
